Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform
Ragu Kanagasabai(University of Indianapolis), Jack C. Yalowich(University of Indianapolis), Soumendrakrishna Karmahapatra(University of Indianapolis), Lucas D. Serdar(Duke Medical Center), Terry S. Elton(The Ohio State University), Corey A. Kientz(University of Indianapolis), Mary K. Ritke(University of Indianapolis), Justin J. Ellis(University of Indianapolis)
Cited by 21
Related Papers
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
|Proceedings of the National Academy of Sciences|2002|2k
ATP hydrolysis by UPF1 is required for efficient translation termination at premature stop codons
|Nature Communications|2016|63
hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide
|Molecular Pharmacology|2019|23